<?xml version='1.0' encoding='utf-8'?>
<document id="20371749"><sentence text="Adverse drug reactions in hospitalized psychiatric patients." /><sentence text="Reducing adverse drug reactions (ADRs) is a critical element in providing safe medication use to hospitalized patients" /><sentence text=" There is an abundance of literature describing ADRs and preventable ADRs (pADRs) in hospitalized patients; however, little has been published specific to psychiatric inpatients" /><sentence text=" Further knowledge of the most common pADRs in hospitalized psychiatric patients will allow targeted patient safety initiatives to be developed" /><sentence text="" /><sentence text="To determine the most frequent ADRs and pADRs in a psychiatric hospital, with emphasis on identifying factors for prevention" /><sentence text="" /><sentence text="Three years of ADRs at a psychiatric hospital were analyzed and evaluated according to type of medication, preventability, severity, and factors associated with preventability" /><sentence text="" /><sentence text="From July 1, 2006, to June 30, 2009, 93 ADRs were reported; 19 (20" /><sentence text="4%) were classified as preventable" /><sentence text=" Psychiatric medications accounted for 45 (48" /><sentence text="4%) of the ADRs and nonpsychiatric medications were associated with 48 (51" /><sentence text="6%)" /><sentence text=" Cardiovascular agents (n = 17) and antiepileptics (n = 17) were responsible for most ADRs" /><sentence text=" Of the 19 pADRs, lithium was the drug reported most frequently, followed by phenytoin and anxiolytics"><entity charOffset="18-25" id="DDI-PubMed.20371749.s16.e0" text="lithium" /><entity charOffset="77-86" id="DDI-PubMed.20371749.s16.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.20371749.s16.e0" e2="DDI-PubMed.20371749.s16.e0" /><pair ddi="false" e1="DDI-PubMed.20371749.s16.e0" e2="DDI-PubMed.20371749.s16.e1" /></sentence><sentence text=" Nine (47%) of the pADRs were severe and required a medical transfer for management; 3 of the 9 were lithium toxicity"><entity charOffset="101-108" id="DDI-PubMed.20371749.s17.e0" text="lithium" /></sentence><sentence text=" The most common preventability factor involved drug interactions" /><sentence text=" A pharmacy intervention involving staff education to reduce lithium pADRs is presented"><entity charOffset="61-74" id="DDI-PubMed.20371749.s19.e0" text="lithium pADRs" /></sentence><sentence text="" /><sentence text="Awareness of the most frequent drug classes associated with ADRs and pADRs in a psychiatric hospital allows opportunity for education, medication management system changes, and improved patient safety" /><sentence text=" Lithium, followed by phenytoin and anxiolytics, were the most common drugs associated with pADRs"><entity charOffset="1-8" id="DDI-PubMed.20371749.s22.e0" text="Lithium" /><entity charOffset="22-31" id="DDI-PubMed.20371749.s22.e1" text="phenytoin" /><pair ddi="false" e1="DDI-PubMed.20371749.s22.e0" e2="DDI-PubMed.20371749.s22.e0" /><pair ddi="false" e1="DDI-PubMed.20371749.s22.e0" e2="DDI-PubMed.20371749.s22.e1" /></sentence><sentence text=" A drug-drug interaction was the most frequent factor associated with pADRs" /><sentence text="" /></document>